HR9969Referred to Committee

To direct the Federal Trade Commission to conduct an investigation and submit to Congress a report on unfair or deceptive acts or practices that may be prevalent in the advertising or marketing of preterm infant formula and to issue regulations to prohibit unfair or deceptive acts or practices related to the advertising or marketing of preterm infant formula, and for other purposes.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-07-27
Introduced
1
Cosponsors
HR
ⓘ
Type

Sponsor

Chris Pappas
Chris Pappas
Democrat · NH · Representative
Votes with party: 92.5% (639 recorded votes)

Full profile: /officials/P000614

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2026-07-27

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

The Federal Trade Commission would be required to investigate whether companies are using misleading or unfair advertising when marketing specialized infant formula designed for premature babies, then report their findings to Congress. Based on what they find, the FTC would be authorized to create new rules to stop any deceptive marketing practices in this industry. This would protect parents and hospitals from being misled about the benefits or contents of these medical products.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.